Open AccessProjections of cancer incidence and cancer‐related deaths in Germany by 2020 and 2030
Author(s) -
Quante Anne S.,
Ming Chang,
Rottmann Miriam,
Engel Jutta,
Boeck Stefan,
Heinemann Volker,
Westphalen Christoph Benedikt,
Strauch Konstantin
Publication year - 2016
Publication title -
cancer medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.403
H-Index - 53
ISSN - 2045-7634
DOI - 10.1002/cam4.767
Subject(s) - cancer , medicine , breast cancer , prostate cancer , pancreatic cancer , incidence (geometry) , colorectal cancer , liver cancer , malignancy , lung cancer , disease , cancer incidence , population , cause of death , oncology , environmental health , physics , optics
Past patterns of cancer disease and future changes in the demographic structure have a major influence on the projected incidences of human malignancies. In Germany, nearly a quarter of men and 20% of women die of cancer, and it is estimated that in Germany around 51% men and 43% women will develop cancer during lifetime. Here, we project the cancer incidence case number as well as the number of deaths for the most common cancers in the German population for the years 2020 and 2030. By 2030, prostate cancer will be the most common malignancy, surpassing breast cancer. Lung cancer will rank third most frequent cancer and will remain the most common cause of cancer‐related mortality. Additionally, our projections show a marked increase in liver cancer cases with a continuous rise in liver cancer‐related deaths. Finally, we project a constant increase in the incidence of pancreatic cancer. Based on our projections, pancreatic cancer will surpass colorectal and breast cancer to rank as the second most common cause of cancer‐related deaths in Germany by 2030.